Metacognitions	O
Are	O
Associated	O
with	O
Subjective	O
Memory	B-DS
Problems	I-DS
in	O
Individuals	O
on	O
Sick	O
Leave	O
due	O
to	O
Chronic	O
Fatigue	O

Edited	O
by	O
:	O
Lorys	O
Castelli	O
,	O
University	O
of	O
Turin	O
,	O
Italy	O

Reviewed	O
by	O
:	O
Christina	O
Karatzaferi	O
,	O
University	O
of	O
St	O
.	O
Mark	O
and	O
St	O
.	O
John	O
,	O
UK	O
;	O
Claudia	O
Cormio	O
,	O
National	O
Cancer	O
Research	O
Institute	O
“	O
Giovanni	O
Paolo	O
II	O
”,	O
Italy	O

This	O
article	O
was	O
submitted	O
to	O
Psychology	O
for	O
Clinical	O
Settings	O
,	O
a	O
section	O
of	O
the	O
journal	O
Frontiers	O
in	O
Psychology	O

Background	O
:	O
Subjective	O
cognitive	B-DS
impairments	I-DS
are	O
frequent	O
,	O
but	O
poorly	O
understood	O
in	O
patients	O
with	O
chronic	O
fatigue	O
.	O

We	O
hypothesized	O
that	O
maladaptive	O
metacognitive	O
beliefs	O
at	O
baseline	O
were	O
associated	O
with	O
baseline	O
subjective	O
cognitive	B-DS
impairments	I-DS
,	O
that	O
they	O
predict	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
,	O
and	O
that	O
a	O
reduction	O
in	O
maladaptive	O
metacognitive	O
beliefs	O
was	O
associated	O
with	O
less	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
,	O
independent	O
of	O
changes	O
in	O
fatigue	O
,	O
pain	O
,	O
insomnia	B-DS
,	O
depression	B-DS
,	O
and	O
anxiety	B-DS
.	O

Methods	O
:	O
In	O
this	O
non	O
-	O
controlled	O
study	O
,	O
patients	O
(	O
n	O
=	O
137	O
)	O
on	O
sick	O
leave	O
due	O
to	O
chronic	O
fatigue	O
received	O
a	O
3	O
.	O
5	O
-	O
week	O
inpatient	O
RTW	O
rehabilitation	O
program	O
.	O

Of	O
these	O
patients	O
69	O
(	O
50	O
.	O
4	O
%)	O
was	O
referred	O
with	O
a	O
ICPC	O
-	O
2	O
diagnosis	O
of	O
chronic	O
fatigue	O
.	O

Patients	O
completed	O
questionnaires	O
about	O
metacognitive	O
beliefs	O
,	O
somatic	O
complaints	O
,	O
psychological	O
complaints	O
,	O
and	O
cognitive	B-DS
impairments	I-DS
before	O
and	O
after	O
treatment	O
.	O

To	O
test	O
the	O
hypotheses	O
we	O
performed	O
paired	O
t	O
-	O
tests	O
of	O
change	O
,	O
as	O
well	O
as	O
seven	O
hierarchical	O
linear	O
regressions	O
.	O

Results	O
:	O
Results	O
showed	O
that	O
baseline	O
maladaptive	O
metacognitive	O
beliefs	O
were	O
significantly	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
baseline	O
,	O
controlling	O
for	O
symptoms	O
.	O

Score	O
on	O
baseline	O
metacognitive	O
beliefs	O
did	O
not	O
predict	O
impairments	O
post	O
-	O
treatment	O
.	O

Testing	O
specific	O
maladaptive	O
beliefs	O
,	O
pre	O
-	O
treatment	O
scores	O
on	O
cognitive	O
confidence	O
were	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
both	O
pre	O
and	O
post	O
-	O
treatment	O
,	O
controlling	O
for	O
symptoms	O
.	O

Post	O
-	O
treatment	O
metacognitive	O
beliefs	O
and	O
post	O
-	O
treatment	O
cognitive	O
confidence	O
were	O
associated	O
with	O
post	O
-	O
treatment	O
subjective	O
cognitive	B-DS
impairments	I-DS
,	O
controlling	O
for	O
pre	O
-	O
treatment	O
impairments	O
and	O
pre	O
-	O
treatment	O
metacognitive	O
beliefs	O
,	O
as	O
well	O
as	O
pre	O
and	O
post	O
-	O
scores	O
on	O
symptom	O
measures	O
.	O

Conclusion	O
:	O
This	O
study	O
reports	O
associations	O
between	O
maladaptive	O
metacognitive	O
beliefs	O
and	O
subjective	O
cognitive	B-DS
impairments	I-DS
in	O
patients	O
with	O
chronic	O
fatigue	O
.	O

Targeting	O
metacognitive	O
beliefs	O
could	O
prove	O
an	O
effective	O
therapeutic	O
intervention	O
for	O
subjective	O
cognitive	B-DS
impairments	I-DS
in	O
these	O
patients	O
.	O

Introduction	O

Chronic	B-DS
fatigue	I-DS
syndrome	I-DS
(	O
CFS	B-DS
)	O
is	O
a	O
prevalent	O
condition	O
characterized	O
by	O
persistent	O
mental	O
and	O
somatic	O
fatigue	O
(	O
Loge	O
et	O
al	O
.,	O
1998	O
;	O
McCrone	O
et	O
al	O
.,	O
2003	O
).	O

Unfortunately	O
,	O
little	O
ground	O
has	O
been	O
made	O
when	O
it	O
comes	O
to	O
understanding	O
its	O
etiology	O
,	O
agreeing	O
on	O
a	O
case	O
definition	O
,	O
or	O
providing	O
patients	O
with	O
efficacious	O
treatments	O
(	O
Castell	O
et	O
al	O
.,	O
2011	O
).	O

This	O
has	O
led	O
to	O
symptom	O
measures	O
often	O
being	O
argued	O
as	O
the	O
best	O
way	O
to	O
classify	O
and	O
investigate	O
these	O
patients	O
(	O
Brurberg	O
et	O
al	O
.,	O
2014	O
).	O

One	O
of	O
several	O
criteria	O
for	O
fulfilling	O
a	O
CFS	B-DS
case	O
definition	O
is	O
reporting	O
problems	O
with	O
forgetfulness	O
,	O
increased	O
distractibility	O
,	O
and	O
reduced	O
mental	O
alertness	O
(	O
Fukuda	O
et	O
al	O
.,	O
1994	O
;	O
Jason	O
et	O
al	O
.,	O
2004	O
).	O

These	O
subjective	O
cognitive	O
complaints	O
or	O
impairments	O
are	O
part	O
of	O
all	O
popular	O
CFS	B-DS
classifications	O
(	O
Holmes	O
et	O
al	O
.,	O
1988	O
;	O
Sharpe	O
et	O
al	O
.,	O
1991	O
)	O
making	O
them	O
a	O
hallmark	O
of	O
the	O
disorder	O
(	O
Jason	O
et	O
al	O
.,	O
2004	O
).	O

Their	O
importance	O
is	O
underlined	O
by	O
90	O
%	O
of	O
CFS	B-DS
patients	O
rating	O
problems	O
with	O
memory	O
and	O
concentration	O
as	O
a	O
primary	O
concern	O
(	O
Jason	O
et	O
al	O
.,	O
1999	O
).	O

Memory	O
and	O
concentration	O
are	O
cognitive	O
capabilities	O
usually	O
defined	O
within	O
the	O
overarching	O
term	O
“	O
executive	O
control	O
functioning	O
”	O
(	O
Miyake	O
and	O
Friedman	O
,	O
2012	O
).	O

Executive	O
control	O
includes	O
many	O
aspects	O
such	O
as	O
the	O
control	O
of	O
attention	O
,	O
the	O
capacity	O
to	O
access	O
and	O
manipulate	O
information	O
in	O
long	O
-	O
term	O
memory	O
,	O
as	O
well	O
as	O
monitoring	O
current	O
internal	O
and	O
external	O
states	O
(	O
Funahashi	O
,	O
2001	O
).	O

CFS	B-DS
patients	O
report	O
a	O
perceived	O
inability	O
to	O
perform	O
cognitive	O
tasks	O
and	O
some	O
data	O
indicates	O
that	O
CFS	B-DS
patients	O
have	O
a	O
lowered	O
performance	O
on	O
objective	O
neuropsychological	O
tests	O
(	O
Michiels	O
and	O
Cluydts	O
,	O
2001	O
).	O

However	O
,	O
this	O
objective	O
bias	O
appears	O
to	O
only	O
be	O
present	O
when	O
the	O
tasks	O
are	O
highly	O
demanding	O
(	O
Dobbs	O
et	O
al	O
.,	O
2001	O
;	O
Cook	O
et	O
al	O
.,	O
2007	O
).	O

As	O
an	O
example	O
,	O
performance	O
differences	O
between	O
CFS	B-DS
patients	O
and	O
controls	O
are	O
reported	O
on	O
the	O
modified	O
Paced	O
Auditory	O
Serial	O
Attention	O
Test	O
,	O
but	O
not	O
for	O
a	O
simple	O
number	O
recognition	O
task	O
(	O
Cook	O
et	O
al	O
.,	O
2007	O
).	O

Subjective	O
cognitive	B-DS
impairments	I-DS
on	O
the	O
other	O
hand	O
,	O
are	O
consistently	O
reported	O
(	O
Cockshell	O
and	O
Mathias	O
,	O
2014	O
).	O

Performing	O
demanding	O
cognitive	O
tasks	O
causes	O
mental	O
fatigue	O
(	O
Cook	O
et	O
al	O
.,	O
2007	O
),	O
which	O
here	O
refers	O
to	O
temporary	O
depletion	O
of	O
cognitive	O
resources	O
.	O

Within	O
CFS	B-DS
,	O
mental	O
fatigue	O
has	O
documented	O
effects	O
on	O
attention	O
,	O
working	O
memory	O
,	O
and	O
other	O
executive	O
control	O
processes	O
(	O
Boksem	O
and	O
Tops	O
,	O
2008	O
).	O

Hence	O
,	O
evaluation	O
of	O
predicted	O
rewards	O
and	O
costs	O
quickly	O
becomes	O
relevant	O
.	O

Most	O
of	O
us	O
tend	O
to	O
loose	O
motivation	O
to	O
perform	O
when	O
the	O
energy	O
costs	O
are	O
believed	O
to	O
outweigh	O
rewards	O
(	O
Boksem	O
and	O
Tops	O
,	O
2008	O
).	O

This	O
means	O
that	O
a	O
subjective	O
cost	O
-	O
benefit	O
analysis	O
of	O
mental	O
fatigue	O
,	O
or	O
subjective	O
impairment	O
,	O
could	O
affect	O
patients	O
'	O
objective	O
ability	O
to	O
efficiently	O
attend	O
to	O
,	O
store	O
and	O
retrieve	O
information	O
when	O
solving	O
mental	O
tasks	O
.	O

However	O
,	O
such	O
linking	O
of	O
subjective	O
and	O
objective	O
cognitive	O
functioning	O
in	O
CFS	B-DS
is	O
controversial	O
and	O
not	O
straightforward	O
(	O
Cockshell	O
and	O
Mathias	O
,	O
2014	O
).	O

The	O
foremost	O
example	O
of	O
this	O
is	O
lack	O
of	O
a	O
consistent	O
correlation	O
between	O
tests	O
(	O
Wearden	O
and	O
Appleby	O
,	O
1997	O
),	O
and	O
that	O
both	O
objective	O
performance	O
and	O
perceived	O
problems	O
could	O
be	O
a	O
result	O
of	O
,	O
or	O
influenced	O
by	O
,	O
co	O
-	O
morbid	O
symptoms	O
such	O
as	O
pain	O
,	O
insomnia	B-DS
,	O
depression	B-DS
,	O
and	O
anxiety	B-DS
(	O
Cockshell	O
and	O
Mathias	O
,	O
2014	O
).	O

A	O
recent	O
review	O
argues	O
that	O
subjective	O
and	O
objective	O
measures	O
of	O
cognitive	O
complaints	O
could	O
in	O
fact	O
represent	O
entirely	O
different	O
constructs	O
in	O
these	O
patients	O
(	O
Cockshell	O
and	O
Mathias	O
,	O
2014	O
).	O

Subjective	O
cognitive	O
evaluation	O
can	O
be	O
argued	O
as	O
a	O
form	O
of	O
metacognitive	O
monitoring	O
(	O
Shimamura	O
,	O
2000	O
).	O

The	O
concept	O
of	O
metacognitions	O
has	O
become	O
increasingly	O
popular	O
in	O
psychotherapy	O
research	O
,	O
also	O
within	O
CFS	B-DS
(	O
Fernie	O
et	O
al	O
.,	O
2015	O
).	O

Metacognitions	O
are	O
popularly	O
defined	O
as	O
“	O
beliefs	O
about	O
thinking	O
”	O
or	O
“	O
cognitions	O
about	O
cognition	O
”	O
(	O
Wells	O
,	O
2011	O
),	O
and	O
metacognitive	O
theory	O
is	O
concerned	O
with	O
excessive	O
,	O
sustained	O
verbal	O
thinking	O
,	O
and	O
dwelling	O
on	O
negative	O
emotions	O
or	O
symptoms	O
in	O
the	O
form	O
of	O
rumination	O
and	O
/	O
or	O
worry	O
(	O
Nolen	O
-	O
Hoeksema	O
,	O
2000	O
;	O
Wells	O
,	O
2011	O
).	O

It	O
is	O
a	O
novel	O
perspective	O
associated	O
with	O
symptom	O
severity	O
(	O
Fernie	O
et	O
al	O
.,	O
2015	O
),	O
but	O
targets	O
“	O
perception	O
of	O
”	O
and	O
“	O
dwelling	O
on	O
”	O
symptoms	O
rather	O
than	O
objective	O
changes	O
to	O
metabolism	O
or	O
nociception	O
.	O

Hence	O
,	O
intervening	O
on	O
metacognitions	O
might	O
offer	O
a	O
new	O
treatment	O
approach	O
,	O
especially	O
when	O
it	O
comes	O
to	O
subjective	O
cognitive	O
evaluation	O
.	O

This	O
notion	O
is	O
substantiated	O
by	O
rumination	O
and	O
worry	O
being	O
cognitive	O
processes	O
associated	O
with	O
increased	O
mental	O
fatigue	O
(	O
Querstret	O
and	O
Cropley	O
,	O
2012	O
).	O

Moreover	O
,	O
excessive	O
worry	O
and	O
rumination	O
creates	O
and	O
maintains	O
a	O
specific	O
attention	O
bias	O
toward	O
threats	O
(	O
Nolen	O
-	O
Hoeksema	O
,	O
2000	O
;	O
Maren	O
,	O
2007	O
;	O
Browning	O
et	O
al	O
.,	O
2010	O
).	O

This	O
bias	O
has	O
within	O
metacognitive	O
theory	O
been	O
coined	O
the	O
“	O
cognitive	B-DS
attentional	I-DS
syndrome	I-DS
”	O
(	O
CAS	B-DS
;	O
Wells	O
,	O
2011	O
).	O

It	O
is	O
there	O
described	O
as	O
a	O
metacognitive	O
process	O
,	O
which	O
maintains	O
and	O
exacerbates	O
depression	B-DS
and	O
anxiety	B-DS
.	O

However	O
,	O
the	O
CAS	B-DS
may	O
prove	O
relevant	O
in	O
CFS	B-DS
as	O
well	O
(	O
Maher	O
-	O
Edwards	O
et	O
al	O
.,	O
2011	O
;	O
Fernie	O
et	O
al	O
.,	O
2015	O
),	O
especially	O
considering	O
data	O
showing	O
CFS	B-DS
patients	O
interpreting	O
more	O
bodily	O
sensations	O
as	O
sign	O
of	O
physical	O
disease	O
,	O
compared	O
to	O
depressed	O
and	O
healthy	O
controls	O
(	O
Dendy	O
et	O
al	O
.,	O
2001	O
).	O

Moreover	O
,	O
a	O
study	O
investigating	O
such	O
selective	O
attention	O
show	O
CFS	B-DS
patients	O
having	O
a	O
significant	O
bias	O
toward	O
health	O
-	O
threatening	O
information	O
(	O
Hou	O
et	O
al	O
.,	O
2008	O
).	O

The	O
theoretical	O
model	O
outlining	O
the	O
development	O
and	O
maintenance	O
of	O
CAS	B-DS
is	O
the	O
Self	O
-	O
Regulatory	O
Executive	O
Function	O
(	O
S	O
-	O
REF	O
)	O
model	O
(	O
Wells	O
and	O
Matthews	O
,	O
1996	O
;	O
Wells	O
,	O
2011	O
).	O

This	O
model	O
provides	O
a	O
conceptualization	O
of	O
how	O
metacognitive	O
and	O
cognitive	O
factors	O
could	O
be	O
involved	O
in	O
the	O
top	O
-	O
down	O
control	O
of	O
disorders	O
.	O

A	O
central	O
premise	O
in	O
this	O
model	O
is	O
that	O
all	O
individuals	O
have	O
positive	O
and	O
negative	O
beliefs	O
about	O
thinking	O
that	O
influences	O
their	O
appraisals	O
(	O
e	O
.	O
g	O
.,	O
“	O
I	O
must	O
worry	O
in	O
order	O
to	O
be	O
prepared	O
”	O
or	O
“	O
I	O
cannot	O
control	O
my	O
thoughts	O
”).	O

Another	O
premise	O
is	O
that	O
we	O
have	O
implicit	O
procedural	O
metacognitions	O
or	O
“	O
thinking	O
skills	O
”	O
such	O
as	O
heuristics	O
that	O
influence	O
and	O
shape	O
both	O
our	O
cognition	O
and	O
behavior	O
(	O
Wells	O
and	O
Matthews	O
,	O
1996	O
;	O
Wells	O
,	O
2011	O
).	O

Investigating	O
subjective	O
cognitive	B-DS
impairments	I-DS
in	O
chronic	O
fatigue	O
and	O
whether	O
these	O
are	O
associated	O
with	O
dysfunctional	O
metacognitive	O
beliefs	O
,	O
may	O
further	O
our	O
understanding	O
and	O
treatment	O
of	O
these	O
complaints	O
.	O

As	O
of	O
now	O
,	O
there	O
are	O
no	O
studies	O
investigating	O
this	O
association	O
,	O
but	O
one	O
study	O
showcased	O
the	O
potential	O
relevance	O
of	O
maladaptive	O
metacognitive	O
beliefs	O
in	O
patients	O
with	O
CFS	B-DS
(	O
Fernie	O
et	O
al	O
.,	O
2015	O
).	O

It	O
is	O
particularly	O
interesting	O
to	O
see	O
if	O
maladaptive	O
metacognitive	O
beliefs	O
are	O
associated	O
with	O
subjective	O
cognitive	O
complaints	O
independent	O
of	O
symptoms	O
.	O

Subjective	O
cognitive	B-DS
impairments	I-DS
have	O
previously	O
been	O
reported	O
to	O
predict	O
quality	O
of	O
life	O
and	O
function	O
in	O
CFS	B-DS
,	O
irrespective	O
of	O
co	O
-	O
morbid	O
symptoms	O
(	O
Ray	O
et	O
al	O
.,	O
1997	O
).	O

Testing	O
the	O
independent	O
effect	O
of	O
metacognitions	O
is	O
also	O
important	O
for	O
treatment	O
development	O
.	O

Several	O
promising	O
treatment	O
manuals	O
for	O
metacognitive	O
therapy	O
exist	O
,	O
which	O
could	O
easily	O
be	O
adapted	O
to	O
fit	O
CFS	B-DS
,	O
either	O
as	O
a	O
stand	O
-	O
alone	O
therapy	O
,	O
or	O
as	O
an	O
addition	O
to	O
graded	O
exercise	O
therapy	O
or	O
traditional	O
cognitive	O
therapy	O
.	O

Thus	O
,	O
an	O
investigation	O
of	O
metacognitive	O
beliefs	O
and	O
their	O
association	O
to	O
subjective	O
cognitive	O
complaints	O
in	O
patients	O
with	O
chronic	O
fatigue	O
is	O
warranted	O
.	O

The	O
main	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
association	O
of	O
metacognitive	O
beliefs	O
to	O
subjective	O
cognitive	B-DS
impairments	I-DS
in	O
a	O
population	O
reporting	O
chronic	O
fatigue	O
.	O

We	O
hypothesize	O
that	O
maladaptive	O
metacognitive	O
beliefs	O
are	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
baseline	O
,	O
controlling	O
for	O
symptoms	O
of	O
fatigue	O
,	O
pain	O
,	O
insomnia	B-DS
,	O
depression	B-DS
,	O
and	O
anxiety	B-DS
.	O

Moreover	O
,	O
we	O
hypothesize	O
that	O
maladaptive	O
metacognitive	O
beliefs	O
at	O
the	O
start	O
of	O
treatment	O
will	O
predict	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
end	O
.	O

We	O
also	O
hypothesize	O
that	O
a	O
reduction	O
in	O
maladaptive	O
metacognitive	O
beliefs	O
during	O
treatment	O
is	O
associated	O
with	O
less	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
,	O
controlling	O
for	O
the	O
aforementioned	O
symptoms	O
.	O

Methods	O

Setting	O
and	O
participants	O

This	O
study	O
had	O
a	O
pre	O
-	O
post	O
design	O
and	O
was	O
conducted	O
between	O
January	O
2012	O
and	O
June	O
2013	O
through	O
a	O
3	O
,	O
5	O
-	O
week	O
in	O
-	O
patient	O
,	O
Return	O
-	O
To	O
-	O
Work	O
(	O
RTW	O
)	O
occupational	O
rehabilitation	O
program	O
at	O
Hysnes	O
Rehabilitation	O
Center	O
,	O
St	O
.	O
Olav	O
'	O
s	O
University	O
Hospital	O
,	O
Trondheim	O
,	O
Norway	O
.	O

In	O
Norway	O
a	O
work	O
week	O
includes	O
working	O
Monday	O
through	O
Friday	O
,	O
or	O
5	O
days	O
of	O
work	O
of	O
7	O
,	O
5	O
h	O
each	O
.	O

A	O
work	O
week	O
is	O
then	O
37	O
,	O
5	O
h	O
in	O
total	O
.	O

Since	O
the	O
program	O
lasted	O
3	O
work	O
weeks	O
and	O
2	O
work	O
days	O
,	O
it	O
consisted	O
of	O
a	O
total	O
of	O
17	O
,	O
7	O
,	O
5	O
-	O
h	O
workdays	O
during	O
which	O
there	O
was	O
an	O
active	O
intervention	O
from	O
the	O
institution	O
.	O

The	O
intervention	O
was	O
shaped	O
this	O
way	O
to	O
emulate	O
a	O
normal	O
work	O
week	O
making	O
the	O
transition	O
to	O
work	O
life	O
easier	O
for	O
the	O
patients	O
.	O

The	O
choice	O
of	O
an	O
inpatient	O
setting	O
for	O
this	O
program	O
was	O
due	O
to	O
geographical	O
challenges	O
specific	O
to	O
Norway	O
.	O

However	O
,	O
the	O
treatment	O
delivered	O
did	O
not	O
exceed	O
that	O
of	O
a	O
day	O
-	O
based	O
outpatient	O
program	O
with	O
regard	O
to	O
hours	O
and	O
available	O
personnel	O
(	O
total	O
availability	O
and	O
treatment	O
was	O
6	O
.	O
5	O
h	O
from	O
8	O
:	O
30	O
a	O
.	O
m	O
.	O
to	O
3	O
:	O
00	O
p	O
.	O
m	O
.).	O

For	O
details	O
about	O
the	O
intervention	O
see	O
Fimland	O
et	O
al	O
.	O
(	O
2014	O
).	O

Prior	O
to	O
the	O
enrolment	O
in	O
this	O
program	O
,	O
the	O
patients	O
had	O
been	O
referred	O
from	O
their	O
general	O
practitioner	O
and	O
examined	O
by	O
an	O
outpatient	O
multidisciplinary	O
team	O
consisting	O
of	O
a	O
physician	O
,	O
a	O
psychologist	O
,	O
and	O
a	O
physiotherapist	O
.	O

This	O
team	O
evaluated	O
whether	O
the	O
referred	O
patients	O
met	O
the	O
requirements	O
for	O
participating	O
in	O
the	O
RTW	O
-	O
program	O
,	O
which	O
included	O
,	O
but	O
were	O
not	O
limited	O
to	O
the	O
inclusion	O
and	O
exclusion	O
criteria	O
for	O
the	O
current	O
study	O
.	O

Before	O
beginning	O
the	O
rehabilitation	O
program	O
,	O
all	O
patients	O
were	O
asked	O
to	O
complete	O
different	O
questionnaires	O
through	O
an	O
internet	O
-	O
administrated	O
self	O
-	O
report	O
survey	O
.	O

At	O
the	O
end	O
of	O
the	O
study	O
,	O
which	O
coincided	O
with	O
the	O
end	O
of	O
the	O
rehabilitation	O
program	O
,	O
the	O
patients	O
again	O
answered	O
several	O
questionnaires	O
.	O

The	O
inclusion	O
criteria	O
for	O
the	O
study	O
were	O
age	O
(	O
18	O
to	O
59	O
years	O
)	O
and	O
having	O
been	O
on	O
sick	O
leave	O
for	O
at	O
least	O
8	O
weeks	O
due	O
to	O
fatigue	O
.	O

Further	O
,	O
participants	O
should	O
have	O
self	O
-	O
defined	O
goals	O
of	O
increasing	O
labor	O
participation	O
,	O
to	O
be	O
adequately	O
assessed	O
and	O
treated	O
beforehand	O
for	O
any	O
specific	O
illnesses	O
,	O
and	O
be	O
able	O
to	O
attend	O
a	O
rehabilitation	O
program	O
from	O
8	O
:	O
30	O
to	O
3	O
:	O
00	O
p	O
.	O
m	O
.	O
all	O
weekdays	O
.	O

The	O
exclusion	O
criteria	O
were	O
severe	O
mental	B-DS
illness	I-DS
(	O
ongoing	O
mania	B-DS
,	O
psychosis	B-DS
or	O
suicidal	O
ideation	O
),	O
substance	B-DS
abuse	I-DS
and	O
addiction	B-DS
or	O
pregnancy	O
.	O

Moreover	O
,	O
patients	O
who	O
could	O
not	O
communicate	O
in	O
Norwegian	O
or	O
who	O
needed	O
24	O
-	O
h	O
personal	O
assistance	O
were	O
not	O
eligible	O
.	O

To	O
be	O
eligible	O
for	O
this	O
study	O
,	O
participants	O
had	O
to	O
report	O
a	O
score	O
of	O
five	O
or	O
more	O
on	O
the	O
fatigue	O
questionnaire	O
,	O
a	O
cut	O
-	O
off	O
validated	O
through	O
previous	O
studies	O
of	O
Norwegian	O
adults	O
(	O
Loge	O
et	O
al	O
.,	O
1998	O
).	O

Moreover	O
,	O
to	O
be	O
included	O
in	O
all	O
the	O
planned	O
steps	O
of	O
analyses	O
,	O
the	O
patients	O
could	O
not	O
have	O
any	O
missing	O
data	O
on	O
any	O
of	O
the	O
independent	O
variables	O
or	O
covariates	O
targeted	O
in	O
the	O
subsequent	O
multivariable	O
analyses	O
.	O

Hence	O
,	O
the	O
study	O
population	O
consisted	O
of	O
patients	O
meeting	O
these	O
criteria	O
who	O
upon	O
inclusion	O
in	O
the	O
program	O
gave	O
their	O
informed	O
consent	O
.	O

The	O
Regional	O
Committee	O
for	O
Ethics	O
in	O
Medical	O
Research	O
approved	O
this	O
study	O
and	O
it	O
was	O
conducted	O
in	O
accordance	O
with	O
the	O
declaration	O
of	O
Helsinki	O
.	O

The	O
study	O
was	O
registered	O
in	O
clinicaltrials	O
.	O
gov	O
(	O
ID	O
:	O
NCT01568970	O
).	O

The	O
rehabilitation	O
program	O

Details	O
on	O
the	O
rehabilitation	O
program	O
are	O
published	O
elsewhere	O
(	O
Fimland	O
et	O
al	O
.,	O
2014	O
).	O

In	O
brief	O
,	O
the	O
program	O
used	O
a	O
combination	O
of	O
group	O
treatment	O
(	O
8	O
patients	O
per	O
group	O
)	O
and	O
individual	O
approaches	O
to	O
facilitate	O
rehabilitation	O
.	O

The	O
participants	O
were	O
organized	O
with	O
activities	O
through	O
7	O
-	O
h	O
workdays	O
and	O
the	O
program	O
lasted	O
for	O
a	O
total	O
of	O
17	O
workdays	O
with	O
Acceptance	O
and	O
Commitment	O
Therapy	O
(	O
ACT	O
)	O
as	O
the	O
overarching	O
treatment	O
model	O
.	O

Therapists	O
targeted	O
three	O
areas	O
of	O
rehabilitation	O
:	O
mental	O
training	O
,	O
physical	O
training	O
,	O
and	O
work	O
-	O
related	O
problem	O
solving	O
.	O

Measures	O

The	O
participant	O
'	O
s	O
demographics	O
were	O
reported	O
through	O
a	O
standardized	O
set	O
of	O
questions	O
validated	O
for	O
a	O
large	O
Norwegian	O
cohort	O
(	O
Holmen	O
et	O
al	O
.,	O
2003	O
),	O
which	O
is	O
also	O
detailed	O
in	O
previous	O
studies	O
(	O
Jacobsen	O
et	O
al	O
.,	O
2014	O
;	O
Kallestad	O
et	O
al	O
.,	O
2015	O
).	O

Dependent	O
variable	O

Subjective	O
cognitive	O
complaints	O
were	O
reported	O
using	O
The	O
Everyday	O
Memory	O
Questionnaire	O
-	O
Revised	O
(	O
EMQ	O
)	O
(	O
Royle	O
and	O
Lincoln	O
,	O
2008	O
).	O

The	O
EMQ	O
-	O
Revised	O
is	O
a	O
13	O
-	O
item	O
measure	O
with	O
two	O
main	O
factors	O
of	O
retrieval	O
and	O
attentional	O
tracking	O
,	O
reduced	O
from	O
an	O
original	O
34	O
-	O
item	O
questionnaire	O
(	O
Royle	O
and	O
Lincoln	O
,	O
2008	O
).	O

Reliability	O
tests	O
on	O
the	O
EMQ	O
have	O
shown	O
a	O
strong	O
internal	O
reliability	O
,	O
with	O
a	O
Cronbachs	O
'	O
Alfa	O
score	O
of	O
.	O
89	O
.	O

Each	O
question	O
is	O
rated	O
on	O
a	O
5	O
-	O
point	O
scale	O
ranging	O
from	O
A	O
,	O
scored	O
as	O
one	O
—“	O
Once	O
or	O
less	O
in	O
the	O
last	O
month	O
,”	O
to	O
E	O
,	O
scored	O
as	O
five	O
—“	O
Once	O
or	O
more	O
in	O
a	O
day	O
.”	O
These	O
items	O
are	O
summed	O
and	O
give	O
an	O
ordinal	O
scale	O
with	O
a	O
range	O
of	O
0	O
to	O
64	O
.	O

Independent	O
variables	O
and	O
covariates	O

The	O
Chalder	O
Fatigue	O
Questionnaire	O
(	O
Chalder	O
et	O
al	O
.,	O
1993	O
)	O
consists	O
of	O
eleven	O
questions	O
asking	O
about	O
physical	O
and	O
mental	O
fatigue	O
and	O
is	O
frequently	O
used	O
to	O
measure	O
symptoms	O
in	O
chronic	O
fatigue	O
patients	O
.	O

Each	O
item	O
has	O
four	O
response	O
categories	O
(	O
0	O
-	O
4	O
),	O
which	O
are	O
scored	O
bi	O
-	O
modally	O
0	O
-	O
0	O
-	O
1	O
-	O
1	O
.	O

When	O
scored	O
,	O
the	O
11	O
items	O
are	O
summed	O
and	O
gives	O
each	O
participant	O
a	O
score	O
on	O
a	O
scale	O
of	O
0	O
–	O
11	O
.	O

This	O
eleven	O
-	O
item	O
scale	O
has	O
been	O
validated	O
for	O
a	O
Norwegian	O
adult	O
population	O
with	O
a	O
cut	O
-	O
off	O
on	O
symptom	O
intensity	O
≥	O
5	O
.	O

Cronbach	O
'	O
s	O
alpha	O
has	O
been	O
calculated	O
for	O
all	O
items	O
(	O
range	O
0	O
.	O
88	O
–	O
0	O
.	O
90	O
).	O

Split	O
half	O
reliability	O
has	O
also	O
been	O
calculated	O
(	O
0	O
.	O
86	O
and	O
0	O
.	O
85	O
,	O
respectively	O
)	O
(	O
Loge	O
et	O
al	O
.,	O
1998	O
).	O

The	O
Metacognitions	O
Questionnaire	O
-	O
30	O
(	O
MCQ	O
-	O
30	O
;	O
Wells	O
and	O
Cartwright	O
-	O
Hatton	O
,	O
2004	O
)	O
asks	O
about	O
metacognitive	O
beliefs	O
through	O
30	O
items	O
,	O
compromising	O
five	O
subscales	O
:	O
(	O
1	O
)	O
Positive	O
beliefs	O
about	O
worry	O
(	O
e	O
.	O
g	O
.,	O
“	O
Worrying	O
helps	O
me	O
cope	O
”);	O
(	O
2	O
)	O
Negative	O
beliefs	O
about	O
uncontrollability	O
and	O
danger	O
of	O
worry	O
(	O
e	O
.	O
g	O
.,	O
“	O
When	O
I	O
start	O
worrying	O
I	O
cannot	O
stop	O
”);	O
(	O
3	O
)	O
Cognitive	O
confidence	O
(	O
e	O
.	O
g	O
.,	O
“	O
I	O
have	O
a	O
poor	O
memory	O
”);	O
(	O
4	O
)	O
Need	O
to	O
control	O
thoughts	O
(	O
e	O
.	O
g	O
.,	O
“	O
Not	O
being	O
able	O
to	O
control	O
my	O
thoughts	O
is	O
a	O
sign	O
of	O
weakness	O
”);	O
(	O
5	O
)	O
Cognitive	O
self	O
-	O
consciousness	O
(	O
e	O
.	O
g	O
.,	O
“	O
I	O
pay	O
close	O
attention	O
to	O
the	O
way	O
my	O
mind	O
works	O
”).	O

Items	O
are	O
scored	O
from	O
1	O
to	O
4	O
(“	O
do	O
not	O
agree	O
,”	O
“	O
agree	O
slightly	O
,”	O
“	O
agree	O
moderately	O
,”	O
“	O
agree	O
very	O
much	O
”),	O
and	O
adding	O
up	O
individual	O
subscale	O
items	O
scores	O
the	O
subscales	O
.	O

Cronbach	O
'	O
s	O
alpha	O
coefficients	O
for	O
these	O
subscales	O
range	O
from	O
0	O
.	O
72	O
to	O
0	O
.	O
93	O
,	O
with	O
test	O
-	O
retest	O
correlations	O
of	O
:	O
0	O
.	O
75	O
(	O
total	O
score	O
),	O
0	O
.	O
79	O
(	O
positive	O
beliefs	O
),	O
0	O
.	O
59	O
(	O
uncontrollability	O
/	O
danger	O
),	O
0	O
.	O
69	O
(	O
cognitive	O
confidence	O
),	O
0	O
.	O
74	O
(	O
need	O
for	O
control	O
),	O
and	O
0	O
.	O
87	O
(	O
cognitive	O
self	O
-	O
consciousness	O
;	O
Wells	O
and	O
Cartwright	O
-	O
Hatton	O
,	O
2004	O
).	O

The	O
Hospital	O
Anxiety	B-DS
and	O
Depression	B-DS
Scale	O
(	O
HADS	O
)	O
(	O
Zigmond	O
and	O
Snaith	O
,	O
1983	O
)	O
asks	O
about	O
symptoms	O
of	O
anxiety	B-DS
and	O
depression	B-DS
.	O

The	O
fourteen	O
-	O
item	O
scale	O
with	O
each	O
item	O
ranging	O
from	O
0	O
to	O
3	O
yields	O
separate	O
scores	O
for	O
anxiety	B-DS
and	O
depression	B-DS
,	O
which	O
are	O
then	O
summed	O
and	O
used	O
as	O
an	O
ordinal	O
scale	O
.	O

In	O
a	O
review	O
of	O
HADS	O
in	O
Norwegian	O
adults	O
the	O
correlations	O
between	O
the	O
two	O
subscales	O
varied	O
from	O
0	O
.	O
40	O
to	O
0	O
.	O
74	O
(	O
mean	O
0	O
.	O
56	O
).	O

Cronbach	O
'	O
s	O
alpha	O
for	O
HADS	O
-	O
A	O
varied	O
from	O
0	O
.	O
68	O
to	O
0	O
.	O
93	O
(	O
mean	O
0	O
.	O
83	O
)	O
and	O
for	O
HADS	O
-	O
D	O
from	O
0	O
.	O
67	O
to	O
0	O
.	O
90	O
(	O
mean	O
0	O
.	O
82	O
;	O
Bjelland	O
et	O
al	O
.,	O
2002	O
).	O

The	O
Insomnia	B-DS
Severity	O
Index	O
(	O
Bastien	O
et	O
al	O
.,	O
2001	O
;	O
ISI	O
)	O
is	O
a	O
seven	O
-	O
item	O
questionnaire	O
assessing	O
sleep	O
problems	O
.	O

A	O
5	O
-	O
point	O
(	O
0	O
–	O
4	O
)	O
scale	O
,	O
rated	O
difficulties	O
falling	O
asleep	O
,	O
night	O
-	O
time	O
awakenings	O
,	O
early	O
morning	O
awakenings	O
,	O
impairment	O
of	O
daytime	O
functioning	O
due	O
to	O
sleep	O
problems	O
,	O
notice	O
ability	O
of	O
impairments	O
,	O
distress	O
or	O
worry	O
caused	O
by	O
sleep	O
difficulties	O
,	O
and	O
dissatisfaction	O
with	O
sleep	O
.	O

The	O
items	O
were	O
summed	O
;	O
giving	O
a	O
scale	O
of	O
0	O
–	O
28	O
,	O
where	O
≥	O
15	O
was	O
used	O
as	O
a	O
moderate	O
cut	O
-	O
off	O
indicating	O
sleep	O
problems	O
.	O

This	O
cut	O
-	O
off	O
has	O
been	O
validated	O
in	O
previous	O
studies	O
and	O
the	O
internal	O
consistency	O
of	O
the	O
ISI	O
was	O
reported	O
to	O
be	O
0	O
.	O
74	O
(	O
Morin	O
et	O
al	O
.,	O
2011	O
).	O

Chronic	O
pain	O
was	O
measured	O
with	O
an	O
item	O
from	O
Short	O
Form	O
-	O
8	O
(	O
Ware	O
et	O
al	O
.,	O
2001	O
)	O
asking	O
“	O
How	O
much	O
bodily	O
pain	O
have	O
you	O
had	O
the	O
last	O
week	O
?”	O
(	O
None	O
,	O
very	O
mild	O
,	O
mild	O
,	O
moderate	O
,	O
severe	O
,	O
and	O
very	O
severe	O
).	O

This	O
scale	O
has	O
been	O
validated	O
as	O
a	O
self	O
-	O
report	O
measure	O
of	O
chronic	O
pain	O
in	O
Norwegian	O
populations	O
.	O

As	O
this	O
is	O
a	O
one	O
-	O
item	O
measurement	O
,	O
alpha	O
values	O
are	O
not	O
applicable	O
.	O

The	O
item	O
has	O
been	O
shown	O
to	O
have	O
an	O
intra	O
-	O
class	O
correlation	O
coefficient	O
of	O
0	O
.	O
66	O
(	O
95	O
%	O
CI	O
0	O
.	O
65	O
to	O
0	O
.	O
67	O
;	O
Landmark	O
et	O
al	O
.,	O
2012	O
).	O

Statistical	O
analysis	O

Demographical	O
data	O
from	O
participants	O
was	O
analyzed	O
using	O
frequencies	O
(	O
dichotomous	O
variables	O
)	O
and	O
means	O
(	O
ordinal	O
variables	O
)	O
with	O
standard	O
deviations	O
.	O

Paired	O
t	O
-	O
tests	O
were	O
performed	O
to	O
investigate	O
significant	O
change	O
from	O
pre	O
to	O
post	O
-	O
treatment	O
on	O
subjective	O
cognitive	B-DS
impairments	I-DS
,	O
maladaptive	O
metacognitions	O
,	O
insomnia	B-DS
,	O
fatigue	O
,	O
pain	O
,	O
depression	B-DS
,	O
and	O
anxiety	B-DS
.	O

To	O
test	O
for	O
associations	O
between	O
maladaptive	O
metacognitive	O
beliefs	O
(	O
MCQ	O
-	O
30	O
)	O
and	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
baseline	O
,	O
we	O
performed	O
two	O
hierarchical	O
linear	O
regression	O
models	O
:	O
First	O
,	O
using	O
subjective	O
cognitive	B-DS
impairments	I-DS
pre	O
-	O
treatment	O
as	O
a	O
dependent	O
variable	O
we	O
performed	O
a	O
hierarchical	O
regression	O
model	O
with	O
two	O
steps	O
.	O

In	O
step	O
one	O
,	O
we	O
entered	O
participants	O
'	O
sex	O
and	O
age	O
,	O
and	O
in	O
step	O
two	O
we	O
entered	O
pre	O
-	O
treatment	O
MCQ	O
-	O
30	O
sum	O
total	O
score	O
.	O

Then	O
,	O
we	O
performed	O
a	O
hierarchical	O
linear	O
regression	O
with	O
three	O
steps	O
.	O

In	O
step	O
one	O
,	O
we	O
entered	O
participants	O
'	O
sex	O
and	O
age	O
,	O
and	O
in	O
step	O
two	O
we	O
entered	O
pre	O
-	O
treatment	O
scores	O
on	O
the	O
five	O
symptom	O
measures	O
.	O

In	O
step	O
three	O
we	O
entered	O
pre	O
-	O
treatment	O
MCQ	O
-	O
30	O
sum	O
total	O
score	O
.	O

Next	O
,	O
we	O
performed	O
a	O
third	O
hierarchical	O
regression	O
model	O
testing	O
the	O
associations	O
of	O
the	O
five	O
subscales	O
of	O
MCQ	O
-	O
30	O
(	O
cognitive	O
confidence	O
,	O
need	O
to	O
control	O
thoughts	O
,	O
positive	O
beliefs	O
,	O
danger	O
/	O
uncontrollability	O
and	O
cognitive	O
consciousness	O
)	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
.	O

In	O
step	O
one	O
,	O
we	O
entered	O
participants	O
'	O
sex	O
and	O
age	O
,	O
and	O
in	O
step	O
two	O
we	O
entered	O
pre	O
-	O
treatment	O
scores	O
on	O
symptom	O
measures	O
.	O

In	O
step	O
three	O
we	O
entered	O
pre	O
-	O
treatment	O
scores	O
on	O
cognitive	O
confidence	O
need	O
to	O
control	O
thoughts	O
,	O
positive	O
beliefs	O
,	O
danger	O
/	O
uncontrollability	O
,	O
and	O
cognitive	O
consciousness	O
.	O

To	O
test	O
whether	O
maladaptive	O
metacognitive	O
beliefs	O
(	O
MCQ	O
-	O
30	O
)	O
at	O
treatment	O
start	O
were	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
,	O
we	O
performed	O
a	O
hierarchical	O
linear	O
regression	O
using	O
subjective	O
cognitive	B-DS
impairments	I-DS
post	O
-	O
treatment	O
as	O
a	O
dependent	O
variable	O
.	O

In	O
this	O
regression	O
model	O
we	O
entered	O
sex	O
and	O
age	O
in	O
step	O
one	O
,	O
in	O
step	O
two	O
we	O
entered	O
pre	O
-	O
treatment	O
values	O
for	O
subjective	O
cognitive	B-DS
impairments	I-DS
.	O

In	O
step	O
three	O
we	O
entered	O
pre	O
-	O
treatment	O
sum	O
total	O
scores	O
for	O
MCQ	O
-	O
30	O
.	O

To	O
test	O
whether	O
a	O
reduction	O
in	O
maladaptive	O
metacognitive	O
beliefs	O
(	O
MCQ	O
-	O
30	O
)	O
were	O
associated	O
with	O
change	O
in	O
subjective	O
cognitive	B-DS
impairments	I-DS
,	O
we	O
added	O
fourth	O
step	O
in	O
the	O
hierarchical	O
linear	O
regression	O
using	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
as	O
the	O
dependent	O
variable	O
.	O

We	O
entered	O
sex	O
and	O
age	O
in	O
step	O
one	O
,	O
in	O
step	O
two	O
we	O
entered	O
pre	O
-	O
treatment	O
scores	O
for	O
subjective	O
cognitive	B-DS
impairments	I-DS
,	O
in	O
step	O
three	O
we	O
entered	O
pre	O
-	O
treatment	O
sum	O
total	O
score	O
for	O
MCQ	O
-	O
30	O
.	O

In	O
step	O
four	O
,	O
we	O
entered	O
the	O
MCQ	O
-	O
30	O
sum	O
total	O
score	O
at	O
treatment	O
end	O
.	O

To	O
test	O
whether	O
maladaptive	O
metacognitive	O
beliefs	O
(	O
MCQ	O
-	O
30	O
)	O
was	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
(	O
EMQ	O
)	O
controlling	O
for	O
levels	O
of	O
fatigue	O
,	O
pain	O
,	O
insomnia	B-DS
,	O
depression	B-DS
,	O
and	O
anxiety	B-DS
,	O
we	O
performed	O
a	O
hierarchical	O
linear	O
regression	O
using	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
as	O
the	O
dependent	O
variable	O
.	O

We	O
entered	O
sex	O
and	O
age	O
in	O
step	O
one	O
,	O
in	O
step	O
two	O
we	O
entered	O
pre	O
-	O
scores	O
for	O
EMQ	O
,	O
and	O
in	O
step	O
three	O
we	O
entered	O
pre	O
-	O
treatment	O
sum	O
total	O
scores	O
on	O
MCQ	O
-	O
30	O
.	O

In	O
step	O
four	O
we	O
entered	O
pre	O
-	O
treatment	O
scores	O
on	O
the	O
five	O
symptom	O
measures	O
.	O

In	O
step	O
five	O
we	O
entered	O
post	O
-	O
treatment	O
sum	O
total	O
scores	O
for	O
MCQ	O
-	O
30	O
and	O
in	O
step	O
six	O
we	O
entered	O
post	O
-	O
treatment	O
scores	O
on	O
the	O
five	O
symptom	O
measures	O
.	O

To	O
test	O
whether	O
the	O
subscales	O
of	O
the	O
maladaptive	O
metacognitive	O
beliefs	O
(	O
MCQ	O
-	O
30	O
)	O
questionnaire	O
were	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
(	O
EMQ	O
)	O
controlling	O
for	O
levels	O
of	O
fatigue	O
,	O
pain	O
,	O
insomnia	B-DS
,	O
depression	B-DS
,	O
and	O
anxiety	B-DS
,	O
we	O
performed	O
a	O
hierarchical	O
linear	O
regression	O
using	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
as	O
the	O
dependent	O
variable	O
.	O

We	O
entered	O
sex	O
and	O
age	O
in	O
step	O
one	O
,	O
in	O
step	O
two	O
we	O
entered	O
pre	O
-	O
scores	O
for	O
EMQ	O
,	O
and	O
in	O
step	O
three	O
we	O
entered	O
pre	O
-	O
treatment	O
scores	O
on	O
the	O
subscales	O
of	O
MCQ	O
-	O
30	O
.	O

In	O
step	O
four	O
we	O
entered	O
pre	O
-	O
treatment	O
scores	O
on	O
the	O
five	O
symptom	O
measures	O
.	O

In	O
step	O
five	O
we	O
entered	O
post	O
-	O
treatment	O
scores	O
on	O
the	O
subscales	O
of	O
MCQ	O
-	O
30	O
and	O
in	O
step	O
six	O
we	O
entered	O
post	O
-	O
treatment	O
scores	O
on	O
the	O
five	O
symptom	O
measures	O
.	O

All	O
analyses	O
were	O
performed	O
using	O
the	O
Statistical	O
Package	O
for	O
the	O
Social	O
Sciences	O
(	O
SPSS	O
version	O
22	O
.	O
0	O
;	O
IBM	O
Corporation	O
,	O
Armonk	O
,	O
NY	O
,	O
USA	O
).	O

In	O
all	O
regressions	O
we	O
estimated	O
correlations	O
and	O
colinearity	O
in	O
order	O
to	O
ensure	O
the	O
validity	O
of	O
the	O
models	O
.	O

Results	O

Population	O
demographics	O

One	O
hundred	O
and	O
eighty	O
-	O
one	O
participants	O
were	O
included	O
in	O
the	O
current	O
study	O
.	O

Of	O
these	O
181	O
participants	O
,	O
137	O
had	O
no	O
missing	O
data	O
,	O
were	O
available	O
for	O
multivariable	O
analysis	O
and	O
t	O
-	O
tests	O
,	O
and	O
represented	O
the	O
study	O
population	O
.	O

All	O
participants	O
reported	O
fatigue	O
above	O
the	O
chosen	O
cut	O
off	O
.	O

They	O
were	O
predominantly	O
female	O
(	O
80	O
.	O
3	O
%)	O
with	O
a	O
mean	O
age	O
of	O
43	O
.	O
6	O
(	O
SD	O
9	O
.	O
4	O
)	O
years	O
,	O
and	O
with	O
education	O
at	O
a	O
high	O
school	O
level	O
or	O
above	O
(	O
87	O
.	O
6	O
%).	O

For	O
an	O
overview	O
of	O
participant	O
characteristics	O
,	O
see	O
Table	O
1	O
.	O

Paired	O
t	O
-	O
tests	O
of	O
change	O
for	O
subjective	O
cognitive	B-DS
impairments	I-DS
and	O
maladaptive	O
metacognitive	O
beliefs	O
are	O
presented	O
in	O
Table	O
2	O
.	O

Characteristics	O
of	O
all	O
included	O
participants	O
(	O
n	O
=	O
137	O
)	O
self	O
-	O
reporting	O
clinically	O
significant	O
physical	O
and	O
mental	O
fatigue	O
when	O
starting	O
inpatient	O
vocational	O
rehabilitation	O
.	O

Demographics	O

Male	O

Female	O

Sex	O
(	O
n	O
)	O

19	O
.	O
7	O
%	O
(	O
27	O
)	O

80	O
.	O
3	O
%	O
(	O
110	O
)	O

Age	O
(	O
SD	O
)	O

41	O
.	O
0	O
(	O
11	O
.	O
8	O
)	O

41	O
.	O
1	O
(	O
9	O
.	O
2	O
)	O

Height	O
—	O
cm	O
(	O
SD	O
)	O

180	O
.	O
4	O
(	O
8	O
.	O
1	O
)	O

166	O
.	O
8	O
(	O
5	O
.	O
9	O
)	O

Weight	O
—	O
kg	O
(	O
SD	O
)	O

88	O
.	O
3	O
(	O
15	O
.	O
7	O
)	O

76	O
.	O
0	O
(	O
16	O
.	O
4	O
)	O

BMI	O
(	O
SD	O
)	O

27	O
.	O
0	O
(	O
4	O
.	O
0	O
)	O

27	O
.	O
3	O
(	O
5	O
.	O
6	O
)	O

Diagnosed	O
chronic	O
fatigue	O
in	O
ICPC	O
-	O
2	O
:	O
A04	O
or	O
P29	O
(	O
n	O
)	O

55	O
.	O
6	O
%	O
(	O
15	O
)	O

49	O
.	O
0	O
%	O
(	O
54	O
)	O

RELATIONSHIP	O
STATUS	O
(	O
n	O
):	O

Married	O
/	O
Living	O
with	O
Partner	O
(	O
n	O
)	O

66	O
.	O
6	O
%	O
(	O
18	O
)	O

70	O
.	O
6	O
%	O
(	O
79	O
)	O

Single	O
/	O
Divorced	O
/	O
Widowed	O
(	O
n	O
)	O

44	O
.	O
4	O
%	O
(	O
9	O
)	O

29	O
.	O
4	O
%	O
(	O
33	O
)	O

EDUCATION	O
(	O
n	O
):	O

Less	O
than	O
High	O
School	O

18	O
.	O
5	O
%	O
(	O
5	O
)	O

18	O
.	O
0	O
%	O
(	O
20	O
)	O

High	O
School	O

40	O
.	O
7	O
%	O
(	O
11	O
)	O

35	O
.	O
1	O
%	O
(	O
39	O
)	O

Some	O
College	O
/	O
University	O

29	O
.	O
6	O
%	O
(	O
8	O
)	O

40	O
.	O
5	O
%	O
(	O
45	O
)	O

Any	O
College	O
/	O
University	O
Degree	O

11	O
.	O
1	O
%	O
(	O
3	O
)	O

6	O
.	O
3	O
%	O
(	O
7	O
)	O

PSYCHIATRIC	O
DIAGNOSES	O
(	O
n	O
):	O

SCID	O
diagnosed	O
Anxiety	B-DS
disorders	I-DS
(	O
F40	O
.	O
1	O
F40	O
.	O
2	O
F41	O
.	O
0	O
F41	O
.	O
1	O
F41	O
.	O
2	O
F41	O
.	O
9	O
F45	O
.	O
2	O
)	O

7	O
.	O
4	O
%	O
(	O
2	O
)	O

9	O
.	O
7	O
%	O
(	O
11	O
)	O

SCID	O
diagnosed	O
Depressive	B-DS
disorders	I-DS
(	O
F32	O
.	O
0	O
F32	O
.	O
1	O
F	O
.	O
33	O
.	O
1	O
F34	O
.	O
1	O
F43	O
.	O
2	O
)	O

7	O
.	O
4	O
%	O
(	O
2	O
)	O

7	O
.	O
1	O
%	O
(	O
8	O
)	O

Self	O
-	O
reported	O
symptoms	O
above	O
cut	O
-	O
off	O

Male	O

Female	O

HADS	O
Depression	B-DS
(	O
n	O
)	O

51	O
.	O
9	O
%	O
(	O
14	O
)	O

42	O
.	O
9	O
%	O
(	O
48	O
)	O

HADS	O
Anxiety	B-DS
(	O
n	O
)	O

55	O
.	O
6	O
%	O
(	O
15	O
)	O

54	O
.	O
9	O
%	O
(	O
62	O
)	O

Chronic	O
Pain	O
(	O
n	O
)	O

59	O
.	O
3	O
%	O
(	O
16	O
)	O

78	O
.	O
8	O
%	O
(	O
89	O
)	O

Sleep	O
Problems	O
(	O
n	O
)	O

33	O
.	O
3	O
%	O
(	O
9	O
)	O

26	O
.	O
5	O
%	O
(	O
30	O
)	O

Categorical	O
characteristics	O
are	O
reported	O
as	O
percent	O
(	O
frequency	O
)	O
and	O
ordinal	O
characteristics	O
as	O
mean	O
(	O
standard	O
deviation	O
).	O

Numbers	O
may	O
not	O
add	O
up	O
to	O
137	O
because	O
of	O
missing	O
data	O
on	O
some	O
characteristics	O
.	O

Percentage	O
is	O
calculated	O
as	O
percentage	O
of	O
total	O
n	O
of	O
the	O
respective	O
sex	O
(	O
male	O
/	O
female	O
).	O

F43	O
.	O
2	O
is	O
categorized	O
as	O
a	O
depressive	B-DS
disorder	I-DS
in	O
this	O
table	O
,	O
however	O
,	O
it	O
could	O
also	O
be	O
classified	O
as	O
an	O
anxiety	B-DS
disorder	I-DS
as	O
it	O
has	O
somewhat	O
overlapping	O
symptoms	O
.	O

Some	O
participants	O
have	O
two	O
SCID	O
diagnoses	O
and	O
were	O
categorized	O
by	O
the	O
primary	O
diagnosis	O
.	O

Averaged	O
change	O
on	O
outcomes	O
,	O
metacognitive	O
beliefs	O
,	O
fatigue	O
,	O
mental	O
distress	O
(	O
including	O
insomnia	B-DS
)	O
and	O
pain	O
reported	O
by	O
participants	O
'	O
pre	O
-	O
post	O
intervention	O
.	O

Variable	O

Pre	O
-	O
treatment	O

Post	O
-	O
treatment	O

Paired	O
samplest	O
-	O
test	O

Mean	O

SD	O

Mean	O

SD	O

t	O

p	O

g	O

COGNITIVE	O
MEASURES	O
:	O

Subjective	O
cognitive	O
complaints	O
(	O
EMQ	O
)	O

30	O
.	O
8	O

12	O
.	O
3	O

29	O
.	O
8	O

12	O
.	O
6	O

1	O
.	O
4	O

0	O
.	O
17	O

0	O
.	O
03	O

MCQ	O
-	O
30	O
total	O

53	O
.	O
8	O

12	O
.	O
2	O

51	O
.	O
0	O

11	O
.	O
2	O

3	O
.	O
9	O

<	O
0	O
.	O
001	O

0	O
.	O
2	O

MCQ	O
SUBSCALES	O
:	O

Cognitive	O
confidence	O

13	O
.	O
1	O

4	O
.	O
6	O

12	O
.	O
1	O

4	O
.	O
4	O

3	O
.	O
2	O

0	O
.	O
002	O

0	O
.	O
15	O

Positive	O
beliefs	O

7	O
.	O
6	O

2	O
.	O
2	O

7	O
.	O
3	O

1	O
.	O
7	O

1	O
.	O
7	O

0	O
.	O
1	O

0	O
.	O
05	O

Cognitive	O
consci	O
.	O

11	O
.	O
8	O

3	O
.	O
4	O

11	O
.	O
8	O

3	O
.	O
5	O

−	O
0	O
.	O
3	O

0	O
.	O
98	O

0	O
.	O
2	O

Uncontrollability	O

11	O
.	O
0	O

3	O
.	O
7	O

11	O
.	O
5	O

3	O
.	O
8	O

−	O
2	O
.	O
0	O

0	O
.	O
05	O

0	O
.	O
2	O

Need	O
to	O
control	O
thoughts	O

9	O
.	O
7	O

3	O
.	O
1	O

9	O
.	O
9	O

3	O
.	O
2	O

−	O
0	O
.	O
9	O

0	O
.	O
35	O

0	O
.	O
2	O

MENTAL	O
DISTRESS	O
,	O
FATIGUE	O
,	O
AND	O
PAIN	O
:	O

Insomnia	B-DS
(	O
ISI	O
)	O

12	O
.	O
2	O

6	O
.	O
1	O

9	O
.	O
8	O

6	O
.	O
4	O

5	O
.	O
53	O

<	O
0	O
.	O
001	O

0	O
.	O
38	O

Pain	O
(	O
SF	O
-	O
8	O
)	O

3	O
.	O
95	O

1	O
.	O
14	O

3	O
.	O
5	O

1	O
.	O
15	O

4	O
.	O
97	O

<	O
0	O
.	O
001	O

0	O
.	O
39	O

Depression	B-DS
(	O
HADS	O
)	O

7	O
.	O
1	O

3	O
.	O
8	O

4	O
.	O
9	O

3	O
.	O
4	O

8	O
.	O
0	O

<	O
0	O
.	O
001	O

0	O
.	O
65	O

Anxiety	B-DS
(	O
HADS	O
)	O

8	O
.	O
2	O

4	O
.	O
2	O

6	O
.	O
2	O

3	O
.	O
8	O

6	O
.	O
6	O

<	O
0	O
.	O
001	O

0	O
.	O
50	O

Fatigue	O
(	O
CFQ	O
)	O

9	O
.	O
0	O

1	O
.	O
8	O

5	O
.	O
7	O

3	O
.	O
9	O

10	O
.	O
6	O

<	O
0	O
.	O
001	O

1	O
.	O
08	O

All	O
variables	O
were	O
significance	O
tested	O
with	O
a	O
paired	O
t	O
-	O
test	O
and	O
degree	O
of	O
change	O
was	O
described	O
as	O
a	O
Hedges	O
g	O
effect	O
size	O
.	O

Hypothesis	O
1	O
:	O
Maladaptive	O
metacognitive	O
beliefs	O
are	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
baseline	O

The	O
sum	O
score	O
on	O
maladaptive	O
metacognitive	O
beliefs	O
(	O
MCQ	O
-	O
30	O
)	O
at	O
baseline	O
was	O
significantly	O
associated	O
with	O
the	O
subjective	O
cognitive	B-DS
impairments	I-DS
(	O
EMQ	O
)	O
sum	O
score	O
at	O
baseline	O
(	O
p	O
<	O
0	O
.	O
0001	O
;	O
t	O
=	O
4	O
.	O
5	O
;	O
B	O
=	O
0	O
.	O
34	O
;	O
95	O
%	O
Confidence	O
Interval	O
of	O
B	O
(	O
CI	O
)	O
=	O
0	O
.	O
19	O
,	O
0	O
.	O
49	O
),	O
controlling	O
for	O
sex	O
,	O
age	O
and	O
pre	O
-	O
scores	O
on	O
symptom	O
scales	O
.	O

Fatigue	O
score	O
pre	O
-	O
treatment	O
(	O
p	O
<	O
0	O
.	O
0001	O
;	O
t	O
=	O
6	O
.	O
4	O
;	O
B	O
=	O
3	O
;	O
CI	O
=	O
2	O
.	O
1	O
,	O
3	O
.	O
9	O
)	O
and	O
depression	B-DS
score	O
pre	O
-	O
treatment	O
(	O
p	O
=	O
0	O
.	O
03	O
;	O
t	O
=	O
−	O
2	O
.	O
2	O
;	O
B	O
=	O
−	O
0	O
.	O
53	O
;	O
CI	O
=	O
−	O
1	O
,	O
−	O
0	O
.	O
61	O
)	O
were	O
also	O
significantly	O
associated	O
with	O
EMQ	O
sum	O
score	O
at	O
baseline	O
.	O

Investigating	O
the	O
subscales	O
of	O
MCQ	O
-	O
30	O
,	O
the	O
subscale	O
of	O
cognitive	O
confidence	O
(	O
p	O
<	O
0	O
.	O
0001	O
;	O
t	O
=	O
8	O
.	O
2	O
;	O
B	O
=	O
1	O
.	O
4	O
;	O
CI	O
=	O
1	O
.	O
1	O
,	O
1	O
.	O
8	O
)	O
was	O
significantly	O
associated	O
with	O
the	O
EMQ	O
sum	O
score	O
,	O
controlling	O
for	O
pre	O
-	O
treatment	O
symptom	O
scores	O
,	O
as	O
was	O
the	O
pre	O
-	O
score	O
on	O
the	O
chosen	O
fatigue	O
scale	O
(	O
p	O
<	O
0	O
.	O
0001	O
;	O
t	O
=	O
3	O
.	O
6	O
;	O
B	O
=	O
1	O
.	O
7	O
;	O
CI	O
=	O
0	O
.	O
77	O
,	O
2	O
.	O
6	O
).	O

The	O
subscales	O
of	O
positive	O
beliefs	O
,	O
need	O
to	O
control	O
thoughts	O
,	O
danger	O
and	O
cognitive	O
consciousness	O
were	O
not	O
.	O

Zero	O
order	O
correlations	O
between	O
the	O
self	O
-	O
report	O
measures	O
ranged	O
from	O
(−	O
0	O
.	O
2	O
to	O
0	O
.	O
6	O
),	O
with	O
cognitive	O
confidence	O
being	O
the	O
highest	O
and	O
need	O
for	O
thought	O
control	O
the	O
lowest	O
.	O

Both	O
collinearity	O
tolerance	O
(	O
1	O
.	O
0	O
–	O
0	O
.	O
5	O
)	O
and	O
variance	O
inflation	O
factor	O
values	O
(	O
1	O
.	O
0	O
–	O
2	O
.	O
4	O
)	O
were	O
acceptable	O
in	O
the	O
regression	O
model	O
.	O

Hypothesis	O
2	O
:	O
Maladaptive	O
metacognitive	O
beliefs	O
pre	O
-	O
treatment	O
are	O
associated	O
with	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O

A	O
hierarchical	O
regression	O
analysis	O
showed	O
that	O
the	O
pre	O
-	O
treatment	O
sum	O
total	O
score	O
on	O
MCQ	O
-	O
30	O
was	O
not	O
associated	O
with	O
EMQ	O
sum	O
score	O
post	O
-	O
treatment	O
,	O
when	O
controlling	O
for	O
pre	O
-	O
scores	O
on	O
the	O
EMQ	O
(	O
p	O
=	O
0	O
.	O
77	O
;	O
t	O
=	O
0	O
.	O
29	O
;	O
B	O
=	O
0	O
.	O
17	O
;	O
CI	O
=	O
−	O
0	O
.	O
1	O
,	O
0	O
.	O
13	O
).	O

As	O
pre	O
-	O
treatment	O
cognitive	O
confidence	O
was	O
the	O
only	O
subscale	O
associated	O
with	O
pre	O
-	O
treatment	O
score	O
on	O
EMQ	O
,	O
we	O
performed	O
an	O
additional	O
analysis	O
looking	O
specifically	O
at	O
this	O
subscale	O
.	O

Pre	O
-	O
treatment	O
scores	O
on	O
cognitive	O
confidence	O
were	O
significantly	O
associated	O
with	O
post	O
-	O
treatment	O
scores	O
on	O
EMQ	O
,	O
controlling	O
for	O
scores	O
on	O
all	O
symptom	O
measures	O
both	O
pre	O
and	O
post	O
-	O
treatment	O
(	O
p	O
<	O
0	O
.	O
0001	O
;	O
t	O
=	O
−	O
3	O
.	O
8	O
;	O
B	O
=	O
−	O
0	O
.	O
7	O
;	O
CI	O
=	O
−	O
1	O
.	O
1	O
,	O
−	O
0	O
.	O
35	O
).	O

Hypothesis	O
3	O
:	O
A	O
reduction	O
in	O
metacognitive	O
beliefs	O
post	O
-	O
treatment	O
is	O
associated	O
with	O
less	O
subjective	O
cognitive	O
complaints	O
at	O
treatment	O
termination	O

Results	O
from	O
a	O
hierarchical	O
regression	O
showed	O
that	O
a	O
reduction	O
on	O
MCQ	O
-	O
30	O
was	O
significantly	O
associated	O
with	O
a	O
reduced	O
post	O
-	O
treatment	O
score	O
on	O
EMQ	O
,	O
controlling	O
for	O
pre	O
-	O
treatment	O
MCQ	O
-	O
30	O
scores	O
,	O
fatigue	O
scores	O
(	O
pre	O
-	O
post	O
),	O
pain	O
(	O
pre	O
-	O
post	O
),	O
insomnia	B-DS
severity	O
(	O
pre	O
-	O
post	O
),	O
anxiety	B-DS
and	O
depression	B-DS
(	O
pre	O
-	O
post	O
)	O
(	O
p	O
<	O
0	O
.	O
0001	O
;	O
t	O
=	O
3	O
.	O
6	O
;	O
B	O
=	O
0	O
.	O
35	O
;	O
CI	O
=	O
0	O
.	O
16	O
,	O
0	O
.	O
5	O
).	O

Analytic	O
details	O
of	O
the	O
regression	O
are	O
presented	O
in	O
Table	O
3	O
.	O

Hierarchical	O
regressions	O
using	O
everyday	O
memory	O
questionnaire	O
(	O
EMQ	O
)	O
post	O
-	O
treatment	O
as	O
a	O
dependent	O
variable	O
and	O
metacognitive	O
questionnaire	O
(	O
MCQ	O
)	O
as	O
an	O
independent	O
variable	O
,	O
controlling	O
for	O
pre	O
-	O
treatment	O
values	O
of	O
EMQ	O
,	O
MCQ	O
,	O
fatigue	O
,	O
pain	O
,	O
insomnia	B-DS
,	O
depressive	O
symptoms	O
and	O
post	O
-	O
treatment	O
values	O
of	O
fatigue	O
,	O
pain	O
and	O
depressive	O
symptoms	O
.	O

Variables	O

Beta	O
Coefficient	O

P	O

95	O
%	O
Confidence	O
Interval	O

Low	O

High	O

STEP	O
1	O
:	O

Sex	O

−	O
0	O
.	O
127	O

0	O
.	O
165	O

−	O
9	O
.	O
421	O

1	O
.	O
628	O

Age	O

0	O
.	O
097	O

0	O
.	O
286	O

−	O
0	O
.	O
119	O

0	O
.	O
400	O

STEP	O
2	O
:	O

Sex	O

−	O
0	O
.	O
080	O

0	O
.	O
142	O

−	O
5	O
.	O
753	O

0	O
.	O
838	O

Age	O

0	O
.	O
048	O

0	O
.	O
374	O

−	O
0	O
.	O
085	O

0	O
.	O
224	O

Pre	O
-	O
treatment	O
EMQ	O

0	O
.	O
798	O

0	O
.	O
000	O

0	O
.	O
691	O

0	O
.	O
906	O

STEP	O
3	O
:	O

Sex	O

−	O
0	O
.	O
080	O

0	O
.	O
145	O

−	O
5	O
.	O
761	O

0	O
.	O
857	O

Age	O

0	O
.	O
048	O

0	O
.	O
375	O

−	O
0	O
.	O
086	O

0	O
.	O
225	O

Pre	O
-	O
treatment	O
EMQ	O

0	O
.	O
793	O

0	O
.	O
000	O

0	O
.	O
678	O

0	O
.	O
908	O

Pre	O
-	O
treatment	O
MCQ	O
-	O
30	O

0	O
.	O
016	O

0	O
.	O
785	O

−	O
0	O
.	O
099	O

0	O
.	O
131	O

STEP	O
4	O
:	O

Sex	O

−	O
2	O
.	O
761	O

0	O
.	O
125	O

−	O
6	O
.	O
305	O

0	O
.	O
783	O

Age	O

0	O
.	O
086	O

0	O
.	O
288	O

−	O
0	O
.	O
074	O

0	O
.	O
246	O

Pre	O
-	O
treatment	O
EMQ	O

0	O
.	O
775	O

0	O
.	O
000	O

0	O
.	O
642	O

0	O
.	O
907	O

Pre	O
-	O
treatment	O
MCQ	O
-	O
30	O

0	O
.	O
050	O

0	O
.	O
452	O

−	O
0	O
.	O
081	O

0	O
.	O
182	O

Pre	O
-	O
treatment	O
Fatigue	O

0	O
.	O
068	O

0	O
.	O
884	O

−	O
0	O
.	O
850	O

0	O
.	O
986	O

Pre	O
-	O
treatment	O
Anxiety	B-DS

−	O
0	O
.	O
204	O

0	O
.	O
315	O

−	O
0	O
.	O
603	O

0	O
.	O
196	O

Pre	O
-	O
treatment	O
Depression	B-DS

−	O
0	O
.	O
183	O

0	O
.	O
414	O

−	O
0	O
.	O
626	O

0	O
.	O
260	O

Pre	O
-	O
treatment	O
Pain	O

−	O
0	O
.	O
237	O

0	O
.	O
707	O

−	O
1	O
.	O
487	O

1	O
.	O
012	O

Pre	O
-	O
treatment	O
Insomnia	B-DS

0	O
.	O
169	O

0	O
.	O
189	O

−	O
0	O
.	O
085	O

0	O
.	O
424	O

STEP	O
5	O
:	O

Sex	O

−	O
2	O
.	O
337	O

0	O
.	O
158	O

−	O
5	O
.	O
597	O

0	O
.	O
923	O

Age	O

0	O
.	O
095	O

0	O
.	O
204	O

−	O
0	O
.	O
052	O

0	O
.	O
242	O

Pre	O
-	O
treatment	O
EMQ	O

0	O
.	O
723	O

0	O
.	O
000	O

0	O
.	O
600	O

0	O
.	O
847	O

Pre	O
-	O
treatment	O
MCQ	O
-	O
30	O

−	O
0	O
.	O
207	O

0	O
.	O
014	O

−	O
0	O
.	O
371	O

−	O
0	O
.	O
044	O

Pre	O
-	O
treatment	O
Fatigue	O

0	O
.	O
145	O

0	O
.	O
734	O

−	O
0	O
.	O
699	O

0	O
.	O
989	O

Pre	O
-	O
treatment	O
Anxiety	B-DS

−	O
0	O
.	O
185	O

0	O
.	O
320	O

−	O
0	O
.	O
552	O

0	O
.	O
182	O

Pre	O
-	O
treatment	O
Depression	B-DS

−	O
0	O
.	O
405	O

0	O
.	O
057	O

−	O
0	O
.	O
823	O

0	O
.	O
013	O

Pre	O
-	O
treatment	O
Pain	O

0	O
.	O
224	O

0	O
.	O
704	O

−	O
0	O
.	O
941	O

1	O
.	O
389	O

Pre	O
-	O
treatment	O
Insomnia	B-DS

0	O
.	O
152	O

0	O
.	O
200	O

−	O
0	O
.	O
082	O

0	O
.	O
385	O

Post	O
-	O
treatment	O
MCQ	O
-	O
30	O

0	O
.	O
411	O

0	O
.	O
000	O

0	O
.	O
235	O

0	O
.	O
587	O

STEP	O
6	O
:	O

Sex	O

−	O
2	O
.	O
330	O

0	O
.	O
162	O

−	O
5	O
.	O
615	O

0	O
.	O
954	O

Age	O

0	O
.	O
054	O

0	O
.	O
459	O

−	O
0	O
.	O
091	O

0	O
.	O
200	O

Pre	O
-	O
treatment	O
EMQ	O

0	O
.	O
728	O

0	O
.	O
000	O

0	O
.	O
608	O

0	O
.	O
849	O

Pre	O
-	O
treatment	O
MCQ	O
-	O
30	O

−	O
0	O
.	O
138	O

0	O
.	O
098	O

−	O
0	O
.	O
302	O

0	O
.	O
026	O

Pre	O
-	O
treatment	O
Fatigue	O

−	O
0	O
.	O
081	O

0	O
.	O
859	O

−	O
0	O
.	O
983	O

0	O
.	O
821	O

Pre	O
-	O
treatment	O
Anxiety	B-DS

0	O
.	O
048	O

0	O
.	O
822	O

−	O
0	O
.	O
375	O

0	O
.	O
471	O

Pre	O
-	O
treatment	O
Depression	B-DS

−	O
0	O
.	O
515	O

0	O
.	O
030	O

−	O
0	O
.	O
981	O

−	O
0	O
.	O
050	O

Pre	O
-	O
treatment	O
Pain	O

−	O
0	O
.	O
342	O

0	O
.	O
613	O

−	O
1	O
.	O
678	O

0	O
.	O
993	O

Pre	O
-	O
treatment	O
Insomnia	B-DS

−	O
0	O
.	O
041	O

0	O
.	O
783	O

−	O
0	O
.	O
332	O

0	O
.	O
251	O

Post	O
-	O
treatment	O
MCQ	O
-	O
30	O

0	O
.	O
347	O

0	O
.	O
000	O

0	O
.	O
156	O

0	O
.	O
538	O

Post	O
-	O
treatment	O
Fatigue	O

0	O
.	O
197	O

0	O
.	O
334	O

−	O
0	O
.	O
205	O

0	O
.	O
599	O

Post	O
-	O
treatment	O
Pain	O

1	O
.	O
350	O

0	O
.	O
054	O

−	O
0	O
.	O
026	O

2	O
.	O
727	O

Post	O
-	O
treatment	O
Insomnia	B-DS

0	O
.	O
182	O

0	O
.	O
239	O

−	O
0	O
.	O
123	O

0	O
.	O
487	O

Post	O
-	O
treatment	O
Anxiety	B-DS

−	O
0	O
.	O
581	O

0	O
.	O
048	O

−	O
1	O
.	O
156	O

−	O
0	O
.	O
006	O

Post	O
-	O
treatment	O
Depression	B-DS

0	O
.	O
517	O

0	O
.	O
095	O

−	O
0	O
.	O
092	O

1	O
.	O
125	O

Everyday	O
memory	O
questionnaire	O
—	O
Revised	O
(	O
EMQ	O
);	O
Metacognitive	O
beliefs	O
questionnaire	O
(	O
MCQ	O
).	O

As	O
pre	O
-	O
treatment	O
cognitive	O
confidence	O
was	O
associated	O
with	O
pre	O
-	O
treatment	O
and	O
post	O
-	O
treatment	O
score	O
on	O
EMQ	O
,	O
we	O
again	O
performed	O
an	O
additional	O
analysis	O
looking	O
specifically	O
at	O
this	O
subscale	O
.	O

Post	O
-	O
treatment	O
scores	O
on	O
cognitive	O
confidence	O
were	O
significantly	O
associated	O
with	O
post	O
-	O
treatment	O
scores	O
on	O
EMQ	O
,	O
controlling	O
for	O
scores	O
on	O
all	O
symptom	O
measures	O
both	O
pre	O
and	O
post	O
-	O
treatment	O
(	O
p	O
<	O
0	O
.	O
0001	O
;	O
t	O
=	O
6	O
.	O
0	O
;	O
B	O
=	O
1	O
.	O
2	O
;	O
CI	O
=	O
0	O
.	O
8	O
,	O
1	O
.	O
7	O
).	O

Discussion	O

This	O
is	O
the	O
first	O
study	O
to	O
report	O
associations	O
between	O
maladaptive	O
metacognitive	O
beliefs	O
and	O
subjective	O
cognitive	B-DS
impairments	I-DS
in	O
chronically	O
fatigued	O
patients	O
.	O

Maladaptive	O
metacognitive	O
beliefs	O
were	O
associated	O
with	O
subjective	O
cognitive	O
complaints	O
at	O
baseline	O
.	O

Investigating	O
the	O
subscales	O
of	O
MCQ	O
-	O
30	O
,	O
only	O
the	O
scale	O
asking	O
beliefs	O
about	O
cognitive	O
confidence	O
had	O
pre	O
-	O
treatment	O
scores	O
associated	O
with	O
pre	O
-	O
treatment	O
subjective	O
cognitive	B-DS
impairments	I-DS
.	O

When	O
looking	O
at	O
whether	O
maladaptive	O
metacognitive	O
beliefs	O
at	O
baseline	O
predicted	O
subjective	O
impairments	O
at	O
treatment	O
end	O
,	O
we	O
found	O
that	O
the	O
sum	O
of	O
MCQ	O
-	O
30	O
did	O
not	O
predict	O
subjective	O
ratings	O
.	O

However	O
,	O
baseline	O
scores	O
on	O
the	O
subscale	O
of	O
cognitive	O
confidence	O
did	O
predict	O
subjective	O
impairments	O
at	O
treatment	O
end	O
.	O

Moreover	O
,	O
when	O
testing	O
if	O
a	O
reduction	O
in	O
sum	O
total	O
maladaptive	O
metacognitive	O
beliefs	O
predicted	O
less	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
,	O
we	O
found	O
a	O
significant	O
association	O
that	O
remained	O
when	O
controlling	O
for	O
baseline	O
subjective	O
cognitive	O
complaints	O
,	O
and	O
pre	O
-	O
post	O
scores	O
on	O
fatigue	O
,	O
pain	O
,	O
insomnia	B-DS
,	O
depression	B-DS
and	O
anxiety	B-DS
.	O

This	O
was	O
also	O
the	O
case	O
for	O
a	O
reduction	O
in	O
post	O
-	O
treatment	O
values	O
on	O
the	O
cognitive	O
confidence	O
subscale	O
,	O
indicating	O
that	O
this	O
subscale	O
is	O
particularly	O
relevant	O
in	O
subjective	O
cognitive	B-DS
impairments	I-DS
.	O

Our	O
finding	O
that	O
baseline	O
metacognitive	O
beliefs	O
concerning	O
cognitive	O
confidence	O
were	O
associated	O
with	O
baseline	O
scores	O
on	O
subjective	O
cognitive	O
complaints	O
is	O
new	O
.	O

According	O
to	O
metacognitive	O
theory	O
,	O
metacognitive	O
beliefs	O
about	O
the	O
lack	O
of	O
cognitive	O
confidence	O
will	O
stop	O
adaptive	O
cognitive	O
coping	O
strategies	O
when	O
patients	O
are	O
feeling	O
mental	O
fatigue	O
.	O

Indeed	O
,	O
maladaptive	O
metacognitive	O
beliefs	O
about	O
cognitive	O
confidence	O
have	O
been	O
previously	O
been	O
associated	O
with	O
symptom	O
severity	O
in	O
CFS	B-DS
patients	O
(	O
Fernie	O
et	O
al	O
.,	O
2015	O
).	O

It	O
is	O
not	O
unlikely	O
then	O
that	O
this	O
association	O
with	O
symptom	O
severity	O
is	O
related	O
to	O
patients	O
'	O
subjective	O
cognitive	B-DS
impairments	I-DS
.	O

This	O
claim	O
is	O
substantiated	O
by	O
memory	O
evaluations	O
,	O
such	O
as	O
our	O
judgments	O
of	O
learning	O
abilities	O
being	O
construed	O
as	O
a	O
specific	O
form	O
of	O
metacognitive	O
monitoring	O
(	O
Shimamura	O
,	O
2000	O
).	O

The	O
current	O
results	O
may	O
have	O
interesting	O
clinical	O
implications	O
.	O

According	O
to	O
recent	O
theorizing	O
in	O
metacognition	O
,	O
cognitive	O
processes	O
are	O
split	O
into	O
two	O
interrelated	O
levels	O
:	O
the	O
meta	O
-	O
level	O
and	O
the	O
object	O
level	O
(	O
Wells	O
,	O
2011	O
).	O

The	O
meta	O
-	O
level	O
contains	O
a	O
cognitive	O
model	O
of	O
the	O
object	O
level	O
,	O
organized	O
according	O
to	O
certain	O
metacognitive	O
principles	O
.	O

The	O
meta	O
-	O
level	O
is	O
continuously	O
updated	O
by	O
bottom	O
-	O
up	O
information	O
,	O
and	O
in	O
return	O
controls	O
the	O
object	O
level	O
by	O
providing	O
top	O
-	O
down	O
input	O
,	O
initiating	O
and	O
terminating	O
actions	O
performed	O
by	O
the	O
object	O
level	O
,	O
here	O
understood	O
as	O
an	O
experience	O
of	O
memory	O
or	O
concentration	O
failure	O
.	O

Thus	O
,	O
metacognitive	O
regulation	O
is	O
a	O
meta	O
-	O
level	O
system	O
that	O
modulates	O
cognitive	O
processes	O
at	O
the	O
lower	O
level	O
.	O

It	O
adds	O
flexibility	O
to	O
cognitive	O
processes	O
,	O
making	O
them	O
less	O
dependent	O
on	O
external	O
cues	O
(	O
Wells	O
,	O
2011	O
).	O

Metacognitions	O
also	O
include	O
self	O
-	O
reflection	O
.	O

The	O
ability	O
to	O
recognize	O
ones	O
own	O
maladaptive	O
behavior	O
and	O
perpetuation	O
of	O
symptoms	O
through	O
rumination	O
and	O
worry	O
is	O
an	O
important	O
metacognitive	O
skill	O
(	O
Wells	O
,	O
2011	O
).	O

Self	O
-	O
reflection	O
is	O
largely	O
a	O
product	O
of	O
early	O
life	O
experiences	O
(	O
Dimaggio	O
et	O
al	O
.,	O
2010	O
),	O
and	O
it	O
is	O
difficult	O
to	O
exclude	O
effects	O
from	O
these	O
experiences	O
in	O
the	O
current	O
study	O
.	O

However	O
,	O
given	O
that	O
one	O
does	O
not	O
have	O
an	O
adequate	O
metacognitive	O
skill	O
to	O
guide	O
actions	O
when	O
experiencing	O
fatigue	O
,	O
this	O
could	O
be	O
a	O
marker	O
for	O
increased	O
risk	O
for	O
developing	O
long	O
-	O
term	O
fatigue	O
.	O

Thus	O
,	O
targeting	O
cognitive	O
confidence	O
both	O
as	O
a	O
screening	O
in	O
patients	O
initially	O
reporting	O
fatigue	O
,	O
subsequently	O
targeting	O
it	O
through	O
metacognitive	O
therapy	O
,	O
could	O
provide	O
us	O
with	O
both	O
a	O
screening	O
tool	O
and	O
a	O
therapeutic	O
intervention	O
.	O

Our	O
finding	O
that	O
cognitive	O
confidence	O
at	O
baseline	O
predicted	O
subjective	O
cognitive	O
complaints	O
at	O
treatment	O
end	O
is	O
also	O
interesting	O
in	O
this	O
regard	O
.	O

Previous	O
data	O
have	O
shown	O
that	O
CFS	B-DS
patient	O
'	O
s	O
objective	O
cognitive	O
abilities	O
will	O
vary	O
over	O
a	O
span	O
of	O
10	O
weeks	O
(	O
Fuentes	O
et	O
al	O
.,	O
2001	O
).	O

It	O
is	O
perhaps	O
indicated	O
here	O
that	O
subjective	O
cognitive	O
evaluations	O
are	O
more	O
stable	O
constructs	O
and	O
therefore	O
a	O
more	O
apt	O
target	O
for	O
intervention	O
.	O

The	O
current	O
results	O
suggest	O
that	O
an	O
intervention	O
on	O
maladaptive	O
metacognitions	O
about	O
cognitive	O
confidence	O
would	O
positively	O
influence	O
subjective	O
evaluations	O
over	O
time	O
.	O

This	O
would	O
potentially	O
alleviate	O
a	O
concern	O
that	O
90	O
%	O
of	O
CFS	B-DS
patients	O
rate	O
as	O
primary	O
and	O
debilitating	O
.	O

The	O
main	O
finding	O
in	O
this	O
study	O
was	O
that	O
a	O
reduction	O
in	O
dysfunctional	O
metacognitive	O
beliefs	O
during	O
treatment	O
was	O
associated	O
with	O
less	O
subjective	O
cognitive	B-DS
impairments	I-DS
at	O
treatment	O
termination	O
.	O

This	O
relationship	O
was	O
not	O
affected	O
by	O
symptoms	O
of	O
fatigue	O
,	O
pain	O
,	O
insomnia	B-DS
,	O
anxiety	B-DS
or	O
depression	B-DS
.	O

Previous	O
studies	O
have	O
attributed	O
subjective	O
cognitive	B-DS
impairments	I-DS
in	O
CFS	B-DS
to	O
the	O
level	O
of	O
depressive	O
symptoms	O
in	O
patients	O
(	O
Wearden	O
and	O
Appleby	O
,	O
1997	O
;	O
Cockshell	O
and	O
Mathias	O
,	O
2014	O
).	O

While	O
depressive	O
symptoms	O
and	O
anxiety	B-DS
also	O
showed	O
a	O
significant	O
association	O
with	O
subjective	O
cognitive	O
complaints	O
in	O
the	O
current	O
study	O
population	O
,	O
they	O
did	O
not	O
influence	O
the	O
unique	O
association	O
with	O
maladaptive	O
metacognitive	O
beliefs	O
.	O

However	O
,	O
the	O
reported	O
relationship	O
between	O
depressive	O
symptoms	O
,	O
anxiety	B-DS
,	O
and	O
subjective	O
cognitive	O
complaints	O
does	O
add	O
a	O
second	O
argument	O
for	O
investigating	O
metacognitions	O
further	O
.	O

Metacognitive	O
therapy	O
has	O
previously	O
shown	O
promising	O
results	O
with	O
depressed	O
patients	O
lacking	O
success	O
from	O
traditional	O
cognitive	O
behavioral	O
therapy	O
(	O
CBT	O
;	O
Wells	O
et	O
al	O
.,	O
2012	O
).	O

Lack	O
of	O
success	O
with	O
CBT	O
is	O
also	O
the	O
case	O
for	O
many	O
chronic	O
fatigue	O
patients	O
(	O
Castell	O
et	O
al	O
.,	O
2011	O
),	O
and	O
metacognitive	O
therapy	O
could	O
be	O
a	O
feasible	O
option	O
for	O
such	O
cases	O
.	O

Moreover	O
,	O
metacognitions	O
have	O
been	O
argued	O
as	O
highly	O
relevant	O
in	O
the	O
development	O
and	O
maintenance	O
of	O
general	O
anxiety	B-DS
disorder	I-DS
(	O
Wells	O
,	O
2005	O
),	O
a	O
diagnosis	O
often	O
comorbid	O
with	O
CFS	B-DS
(	O
Fischler	O
et	O
al	O
.,	O
1997	O
).	O

Of	O
particular	O
relevance	O
to	O
the	O
current	O
results	O
is	O
a	O
recent	O
text	O
comparing	O
subjective	O
vs	O
.	O
objective	O
cognitive	B-DS
impairment	I-DS
in	O
chronic	B-DS
fatigue	I-DS
syndrome	I-DS
(	O
Cockshell	O
and	O
Mathias	O
,	O
2014	O
).	O

The	O
authors	O
argue	O
that	O
these	O
are	O
different	O
concepts	O
entirely	O
.	O

It	O
seems	O
that	O
subjective	O
impairment	O
is	O
somewhat	O
imprecise	O
and	O
more	O
generic	O
,	O
while	O
objective	O
impairments	O
are	O
closely	O
linked	O
to	O
task	O
difficulty	O
(	O
Cockshell	O
and	O
Mathias	O
,	O
2014	O
).	O

Considering	O
this	O
,	O
it	O
is	O
tempting	O
to	O
further	O
speculate	O
on	O
how	O
subjective	O
cognitive	O
complaints	O
could	O
be	O
a	O
prime	O
target	O
for	O
intervention	O
.	O

Perseverative	O
thinking	O
in	O
the	O
form	O
of	O
subjective	O
cognitive	O
complaints	O
may	O
lead	O
to	O
physiological	O
changes	O
or	O
prolonged	O
activation	O
,	O
and	O
that	O
in	O
turn	O
might	O
change	O
the	O
patients	O
experience	O
of	O
fatigue	O
and	O
/	O
or	O
disrupt	O
recovery	O
(	O
Brosschot	O
et	O
al	O
.,	O
2006	O
).	O

Current	O
stress	O
theory	O
argues	O
that	O
by	O
targeting	O
such	O
perseverative	O
thinking	O
,	O
we	O
might	O
be	O
able	O
to	O
ameliorate	O
not	O
only	O
subjective	O
cognitive	O
complaints	O
,	O
but	O
also	O
the	O
intensity	O
and	O
frequency	O
of	O
fatigue	O
symptoms	O
(	O
Brosschot	O
et	O
al	O
.,	O
2006	O
).	O

It	O
is	O
important	O
to	O
note	O
that	O
this	O
study	O
used	O
an	O
ACT	O
intervention	O
,	O
not	O
metacognitive	O
therapy	O
.	O

While	O
our	O
results	O
imply	O
that	O
targeting	O
metacognitive	O
beliefs	O
through	O
metacognitive	O
therapy	O
is	O
perhaps	O
not	O
necessary	O
to	O
change	O
them	O
,	O
it	O
does	O
not	O
answer	O
whether	O
using	O
a	O
therapy	O
specifically	O
focused	O
on	O
changing	O
metacognitive	O
beliefs	O
could	O
increase	O
this	O
change	O
.	O

The	O
reported	O
change	O
in	O
this	O
study	O
is	O
minor	O
,	O
and	O
it	O
could	O
very	O
well	O
be	O
that	O
a	O
targeted	O
metacognitive	O
therapy	O
would	O
have	O
made	O
more	O
impact	O
on	O
the	O
patients	O
'.	O

Limitations	O

The	O
current	O
study	O
has	O
some	O
limitations	O
,	O
the	O
foremost	O
being	O
the	O
lack	O
of	O
a	O
control	O
group	O
.	O

Another	O
limitation	O
is	O
that	O
outcome	O
variables	O
are	O
based	O
on	O
self	O
-	O
report	O
and	O
not	O
clinical	O
or	O
objective	O
evaluations	O
.	O

Self	O
-	O
reported	O
fatigue	O
on	O
the	O
Chalder	O
Fatigue	O
Questionnaire	O
was	O
used	O
as	O
a	O
cut	O
-	O
off	O
for	O
fatigue	O
,	O
opposed	O
to	O
a	O
clinical	O
examination	O
,	O
semi	O
-	O
structured	O
interviews	O
or	O
fitness	O
tests	O
.	O

Thus	O
,	O
the	O
participants	O
'	O
results	O
may	O
not	O
be	O
generalizable	O
to	O
the	O
group	O
of	O
patients	O
who	O
meet	O
the	O
full	O
diagnostic	O
criteria	O
for	O
CFS	B-DS
.	O

However	O
,	O
the	O
mean	O
pre	O
-	O
treatment	O
scores	O
on	O
Chalder	O
Fatigue	O
Scale	O
are	O
in	O
line	O
with	O
other	O
studies	O
of	O
patients	O
with	O
diagnosed	O
CFS	B-DS
(	O
White	O
et	O
al	O
.,	O
2011	O
),	O
and	O
systematic	O
reviews	O
have	O
argued	O
that	O
symptom	O
measures	O
are	O
the	O
best	O
way	O
to	O
evaluate	O
interventions	O
in	O
chronic	O
fatigue	O
(	O
Brurberg	O
et	O
al	O
.,	O
2014	O
).	O

We	O
did	O
not	O
have	O
data	O
on	O
menopause	O
/	O
perimenopause	O
status	O
in	O
our	O
particpants	O
,	O
which	O
could	O
be	O
considered	O
a	O
limitation	O
since	O
this	O
can	O
affect	O
variables	O
measured	O
.	O

It	O
is	O
also	O
a	O
limitation	O
that	O
subjective	O
cognitive	B-DS
impairments	I-DS
were	O
assessed	O
by	O
a	O
questionnaire	O
not	O
an	O
semi	O
-	O
structured	O
interview	O
,	O
however	O
,	O
this	O
is	O
a	O
common	O
way	O
of	O
estimating	O
such	O
impairments	O
.	O

Moreover	O
,	O
with	O
approximately	O
10	O
%	O
of	O
participants	O
reporting	O
an	O
emotional	B-DS
disorder	I-DS
on	O
SCID	O
-	O
I	O
,	O
this	O
might	O
influence	O
the	O
data	O
on	O
maladaptive	O
metacognitions	O
,	O
as	O
these	O
are	O
prevalent	O
in	O
anxiety	B-DS
and	O
depression	B-DS
.	O

Finally	O
,	O
it	O
is	O
a	O
limitation	O
that	O
27	O
%	O
of	O
patients	O
'	O
were	O
excluded	O
because	O
of	O
missing	O
data	O
,	O
and	O
this	O
may	O
have	O
influenced	O
our	O
results	O
.	O

Conclusion	O

This	O
non	O
-	O
controlled	O
study	O
reports	O
significant	O
associations	O
between	O
dysfunctional	O
metacognitive	O
beliefs	O
and	O
subjective	O
cognitive	B-DS
impairments	I-DS
in	O
chronically	O
fatigued	O
patients	O
.	O

These	O
associations	O
highlight	O
the	O
potential	O
importance	O
of	O
targeting	O
maladaptive	O
metacognitive	O
beliefs	O
in	O
chronic	O
fatigue	O
.	O

Finally	O
,	O
our	O
results	O
give	O
cause	O
to	O
investigate	O
metacognitive	O
therapy	O
as	O
a	O
potential	O
supplemental	O
or	O
novel	O
psychological	O
treatment	O
for	O
CFS	B-DS
.	O

Author	O
contributions	O

We	O
all	O
have	O
participated	O
in	O
the	O
conception	O
of	O
this	O
report	O
and	O
have	O
assisted	O
in	O
revising	O
the	O
manuscript	O
for	O
important	O
intellectual	O
content	O
.	O

We	O
have	O
all	O
provided	O
final	O
approval	O
of	O
the	O
enclosed	O
report	O
.	O

More	O
specifically	O
:	O
JA	O
assisted	O
with	O
conceptual	O
framework	O
and	O
writing	O
as	O
well	O
as	O
organized	O
the	O
data	O
collection	O
.	O

PB	O
was	O
the	O
project	O
leader	O
and	O
essential	O
in	O
data	O
collection	O
as	O
well	O
as	O
writing	O
the	O
methods	O
and	O
introduction	O
.	O

NL	O
co	O
-	O
developed	O
the	O
experimental	O
design	O
,	O
study	O
aims	O
and	O
contributed	O
to	O
the	O
discussion	O
.	O

TS	O
supervised	O
the	O
entire	O
production	O
of	O
the	O
manuscript	O
,	O
co	O
-	O
developed	O
the	O
design	O
,	O
helped	O
write	O
the	O
study	O
aims	O
and	O
contributed	O
to	O
the	O
introduction	O
,	O
results	O
and	O
discussion	O
.	O

